¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hearing screening test, newborn"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® hearing test ÇÑ±Û Ã»·Â°Ë»ç
¼³¸í   
  ±Í°¡ µé¸®´Â Á¤µµ¸¦ ÃøÁ¤Çϴ °Ë»ç. Ã»°¢°Ë»ç¶ó°íµµ ÇÑ´Ù. ¼Ò¸®³ª ¸ñ¼Ò¸®°¡ Àß µé¸®´ÂÁöÀÇ ¿©ºÎ µî Ã»°¢ÀÇ ¿¹¹ÎÇÑ Á¤µµ¸¦ ÃøÁ¤Çϴ ÀÏÀÌ´Ù. °Ë»ç¿¡´Â Ã»·Â°è³ª ¼Ò¸®±Á¼è µîÀÇ ±â±¸¿¡ ÀÇÇØ¼­ ¾ò´Â À½¿ø, Áï ¼øÀ½À» »ç¿ëÇϸç, »ç¶÷ÀÇ ¸ñ¼Ò¸®³ª ½Ã°è¼Ò¸® µîµµ À½¿øÀ¸·Î »ç¿ëµÈ´Ù. ¶Ç À½ÆÄ°¡ ÀüÆÄµÇ´Â ¸ÅÁú¿¡ µû¶ó ±âµµ Ã»·Â°Ë»ç¿Í °ñµµ Ã»·Â°Ë»ç·Î ±¸º°µÇ±âµµ ÇÑ´Ù. °Ë»çÀÇ ³»¿ëÀ¸·Î´Â Ã»°¢ÀÇ »óÇÏÀ½°è³ª ÃÖ¼Ò °¡Ã»¹®ÅΰªÀÇ °Ë»ç¸¦ ºñ·ÔÇÏ¿©, ÃæºÐÈ÷ µé¸®´Â ¼Ò¸®¸¦ »ç¿ëÇÏ¿© ±×°ÍÀÌ µé¸®´Â »óŸ¦ Á¶»çÇϴ ¹®Åΰª°Ë»ç(¼Ò¸®ÀÇ Å©±â¿Í »óÅÂÀÇ °Ë»ç, ¼¼±âÀÇ ÆÇº°¿ª°Ë»ç µî) ¿Ü¿¡ À½ÇâÀÚ±ØÀÇ ¹ÝÀÀÀ¸·ÎºÎÅ͠Ÿ°¢ÀûÀ¸·Î Á¶»çÇϴ ¹æ¹ýµµ ÀÖÀ¸¸ç, À̰ÍÀº ÁַΠ°«³­¾Æ±â³ª Á¤½Åº´È¯ÀÚ¿¡ ´ëÇÏ¿© »ç¿ëµÈ´Ù. ÁַΠû·Â°è°¡ »ç¿ëµÇ°í, Ã»·ÂÀº µ¥½Ãº§(dB)·Î Ç¥½ÃµÈ´Ù. Á¤»óÀÎÀº 0dBÀ̰í, ³­Ã»ÀÚÀϼö·Ï ±× ¼ö°¡ Ä¿Áö¸ç, 60dBÀÌ»óÀº »ó´çÈ÷ ³­Ã»À̰í, 80dB ÀÌ»óÀ̸頱͸ӰŸ®ÀÌ´Ù.
¿µ¹® screening ÇÑ±Û °Ë»ö, ¼±º°
¼³¸í   
  1. º¸±â¿¡´Â °Ç°­ÇÑ °Í°ú °°ÀÌ º¸À̸鼭 Áúº´¿¡ °É·ÁÀÖ´Ù°í »ý°¢µÇ´Â »ç¶÷µéÀ» °ñ¶ó³»±â À§ÇÑ °Ë»ç. Áúº´ÀÇ Áø´ÜÀ» ÀǵµÇÑ °ÍÀº ¾Æ´Ï°í ´Ù¼öÀÇ ¼öÀüÀÚ Áß¿¡¼­ ºñ±³Àû °£´ÜÇÑ ¹æ¹ýÀ¸·Î ÀǽÉÀÌ °¡´Â ÀÚ¸¦ °ñ¶ó³»´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. ¼±ÃâµÈ Àڴ ´õ¿í »ó¼¼ÇÑ °Ë»ç¸¦ ¹ÞÀ» Çʿ䰡 ÀÖ´Ù. 2. ½ÃÇèÀ̳ª °Ë»ç¿Í °°Àº ¿¹ºñÀû ÀýÂ÷, Á¶»ç°¡ ´õ ÇÊ¿äÇÑ Àå¾ÖÀÇ °¡Àå Æ¯Â¡ÀûÀΠ¡Èĸ¦ Ã£¾Æ³»±â À§ÇØ ½ÃÇàÇÑ´Ù. 3. Áý´Ü¼±º°°Ë»ç, °íÇ÷¾Ð°ú °°Àº Æ¯Á¤º´À̳ª Àå¾Ö¸¦ Ã£¾Æ³»±â À§ÇØ Å« Ç¥º»À» ÀÌ¿ëÇϴ °Ë»ç.
¿µ¹® newborn infant ÇÑ±Û ½Å»ý¾Æ
¼³¸í   
  ºÐ¸¸ Á÷ÈĺÎÅÍ µ¶¸³µÈ ÀÚ±ÃÀÇ »ýȰÀ» ÇÒ ¼ö Àִ ´É·ÂÀ» È¹µæÇÒ ¶§±îÁöÀÇ ¾ÆÀÌ. ½Å»ý¾Æ´Â »ýÈÄ 4ÁÖÀϱîÁö¸¦ ¸»ÇÑ´Ù. ÀÌ ±â°£¿¡ ½Å»ý¾Æ´Â ¸ðüÀÇ Å ¾È¿¡¼­ ÀÚµ¿ÀûÀ¸·Î »ê¼Ò³ª ¿µ¾çÀ» ¹Þ°í ÀÖ´ø »óÅ¿¡¼­ ÀÚ·ÂÀ¸·Î È£ÈíÀ̳ª ¿µ¾ç ¼·Ã븦 ÇϰԠµÇ´Â ±Þ°ÝÇÑ º¯È­°¡ ÀϾ°í, ÀÌ¿¡ µû¶ó¼­ ÃʱâÀǠü¿ÂÀÇ °­ÇÏ, »ý¸®Àû Ã¼ÁßÀÇ °¨¼Ò, ½Å»ý¾ÆÈ²´Þ, ÅÈÁÙÀÇ Å»¶ô µîÀÇ ¿©·¯ Çö»óÀÌ ÀϾ´Ù. °¨°¢¸é¿¡¼­´Â ¿µ¾ç ¼·Ã븦 À§ÇÑ ÈíÀιݻç´Â Àß ¹ß´ÞµÇ¾î ÀÖÀ¸³ª, ¹Ì°¢Àº ´ë°­ÀÇ ¸ÀÀÇ ÆÇº°, Èİ¢Àº °­ÇÑ ¾ÇÃë¿¡ ´ëÇÑ ¹ÝÀÀ, ½Ã°¢Àº ¸í¾ÏÀ» ÆÇº°Çϴ Á¤µµÀ̸ç, Ã»°¢Àº »ýÈÄ 1ÁÖÀϰæ±îÁö´Â °ÅÀÇ ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â´Ù.
¿µ¹® hemolytic disease of newborn ÇÑ±Û ½Å»ý¾Æ¿ëÇ÷º´
¼³¸í   
  ½Å»ý¾Æ¿¡¼­ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î Å¾ÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼­ »ý»êµÈ ½Å»ý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ Å¹ÝÀ» °Ç³Ê¿Í¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼­ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». ÁŻý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼­ »ý»êÀÌ µÇ°í À̰ÍÀ̠ŹÝÀ» ÅëÇØ¼­ Å¾ƿ¡°Ô ³Ñ¾î°¡¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼­ ºóÇ÷ÀÌ »ý±ä °ÍÀ» Å¾ÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´­ ¼ö°¡ ÀÖ´Ù.
¿µ¹® hearing ÇÑ±Û µè±â, û°¢, û·Â
¼³¸í   
  ¾î¶² ¹üÀ§ÀÇ Á֯ļöÀÇ À½ÆÄ°¡ Ã»°¢±â¸¦ ÀÚ±ØÇÏ¿© »ý±â´Â °¨°¢. À½ÆÄÀÇ Á֯ļö´Â 20Hz¿¡¼­ 2¸¸ Hz(1Hz´Â ¸ÅÃÊ 1»çÀÌŬ)±îÁöÀ̰í, Ã»°¢±â°üÀº ¹Ù±ù±Í-°¡¿îµ¥±Í-¼Ó±Í·Î ±¸ºÐµÈ´Ù. Ã»°¢ ¼ö¿ë±â´Â ¼Ó±ÍÀÇ ´ÞÆØÀ̰ü¿¡ ÀÖ°í, ¹Ù±ù±Í ¹× °¡¿îµ¥±Í´Â À½À» ¼Ó±Í¿¡ Àü´ÞÇϴ ÀüÀ½±âîîëåÐïÀÌ´Ù. ¹Ù±ù±Í´Â ±Ó¹ÙÄû¿Í ¹Ù±ù±Í±æ·Î ÀÌ·ç¾îÁ® ÀÖÀ¸¸ç, °í¸·ÀÌ °¡¿îµ¥±Í¿ÍÀÇ °æ°è¸¦ ÀÌ·é´Ù. °¡¿îµ¥±Í´Â ¸ÁÄ¡»À-¸ð·ç»À-µîÀÚ»À¶ó°í Çϴ ¼¼ °³ÀÇ ±Ó¼Ó»À°¡ ÀÖ¾î °í¸·ÀÇ Áøµ¿À» ´ÞÆØÀ̰üÀÇ ¾È¶ãâ¿¡ Àü´ÞÇÑ´Ù. ÀÌ ¶§ À½ÆÄÀÇ ÁøÆøÀº °¨¼èµÇÁö¸¸ À½¾ÐÀº ¾à 20¹è·Î Áõ°­µÈ´Ù. ´ÞÆØÀ̰üÀº Á¶°³²®µ¥±âÀÇ ³ª»ç ¸ð¾çÀÇ °ñ°üÀ̸ç, È¾´Ü¸é¿¡¼­´Â ±âÀú¸·°ú ¾È¶ã¸·¿¡ ÀÇÇØ ¼¼ ¹æÀ¸·Î ³ª´©¾îÁø´Ù. ¾ç¸·À¸·Î µÑ·¯½ÎÀΠºÎºÐÀÌ ´ÞÆØÀ̰üÀε¥ ³»¸²ÇÁ·Î °¡µæ Â÷ ÀÖ°í, ±× À§¿¡ Àִ ¾È¶ã°è¿Í ¹Ø¿¡ Àִ °í½Ç°è´Â ¿Ü¸²ÇÁ·Î °¡µæ Â÷ ÀÖ´Ù. ±âÀú¸· À§¿¡´Â Åм¼Æ÷°¡ ¹è¿­µÇ¾î ÀÖ´Ù. ¾È¶ãâ¿¡ Àü´ÞµÈ À½ÆÄ´Â ¾È¶ã°èÀÇ ¿Ü¸²ÇÁ¸¦ ÅëÇØ¼­ ´ÞÆØÀ̼¼°üÀÇ ³»¸²ÇÁ·Î ÀüÇØÁö°í ³¡¿¡ °¡¼­´Â ±âÀú¸· À§¿¡ Åм¼Æ÷¿¡ Áøµ¿ÀÚ±ØÀ» ÁÖ°Ô µÈ´Ù. Åм¼Æ÷°¡ ÈïºÐÇϸ頿©±â¿¡ ºÎÂøÇØ Àִ ´ÞÆØÀ̰ü½Å°æÀ¸·Î Ã浿ÀÌ ¹ß»çµÈ´Ù. ´ÞÆØÀ̰ü ½Å°æÀº Á¦8³ú½Å°æÀÇ ÀϺημ­ ¼û³ú¿¡ µé¾î°¡ ¼û³úÀÇ ¿Ã¸®ºêÇÙ, Áß°£³úÀÇ ¾Æ·¡¾ð´ö, ¾ÈÂʹ«¸­Ã¼¿¡ ÀÇÇØ¼­ ¿¬Á¢Àü´ÞÀ» ÇÏ¿© ´ë³ú°ÑÁú °üÀÚ¿±ÀǠû°¢ºÎ¿¡ À̸£·¯ Ã»°¢À» ¹ß»ý½ÃŲ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´Þ¼±º°°Ë»ç
  • screening test
    ¼±º°°Ë»ç
  • newborn
    ½Å»ý¾Æ
  • newborn baby
    ½Å»ý¾Æ
  • newborn behavior assessment scale
    ½Å»ý¾ÆÇൿÆò°¡Ã´µµ
  • newborn infant
    ½Å»ý¾Æ
  • hearing test
    û·Â°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • genetic screening
    À¯Àü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • multiphasic screening
    ´Ù»ó¼±º°°Ë»ç
  • mass screening
    Áý´Ü¼±º°°Ë»ç
  • maternal serum screening
    ¸ðüÇ÷û¼±º°°Ë»ç
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • screening test
    ¼±º°°Ë»ç
  • newborn
    ½Å»ý¾Æ
  • hearing
    µè±â, û°¢, û·Â
  • air conduction hearing
    °ø±âÀüµµµè±â, °ø±âÀüµµÃ»·Â
  • bone conduction hearing
    »ÀÀüµµµè±â, »ÀÀüµµÃ»·Â
  • speech hearing
    ¸»¼Ò¸®µè±â, ¾îÀ½Ã»·Â
  • screening
    °Ë»ö, ¼±º°, °Ë»ç
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
  • nitroblue tetrazolium test
    ´ÏÆ®·Îºí·çÅׯ®¶óÁ¹·ý°Ë»ç
  • test strip
    °Ë»ç¶ì
  • test
    °Ë»ç, ½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • agglutination test
    ÀÀÁý°Ë»ç
  • anticholinesterase test
    Ç×Äݸ°¿¡½ºÅ×¶óÁ¦°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • screening hearing test
    ¼±º°Ã»·Â°Ë»ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • multiphasic screening test
    ´Ù»ó¼±º°°Ë»ç
  • screening test
    ¼±º°°Ë»ç
  • newborn baby
    ½Å»ý¾Æ
  • newborn metabolic disturbance
    ½Å»ý¾Æ´ë»çÀå¾Ö
  • newborn infant
    ½Å»ý¾Æ
  • newborn
    ½Å»ý¾Æ
  • newborn behavior assessment scale
    ¿µ¾ÆÇൿÆò°¡Ã´µµ
  • hearing test
    û·Â°Ë»ç
  • objective hearing test
    Ÿ°¢Ã»·Â°Ë»ç, °´°üÀûû·Â°Ë»ç
  • speech hearing test
    ¸»¼Ò¸®µè±â°Ë»ç, ¾îÀ½Ã»·Â°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • mass screening
    Áý´Ü°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • DDST=Denver developmental screening test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç(Û¡Ó¹ðàÞÛËþÞÛ)
  • Denver developmental screening test
    µ§¹ö¹ßÀ°¼±º°¹ý.
  • Falcon assay screening test
    ÆÈÄܺм®¼±º°½ÃÇè
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • hearing amelioration =hearing improvement, hearin
    û·Â°³¼±
  • hearing distance =hearing range
    û·Â°Å¸®, °¡Ã»°Å¸®
  • ABO hemolytic disease of the newborn
    ½Å»ý¾Æ ABO ¿ëÇ÷¼ºÁúȯ
  • IRDNI=£¾idiopathic respiratory distress of the newborn infant
    ½Å»ý¾Æ Ư¹ß¼º È£Èí°ï¶õÁõ, À¯¸®Áú¸·Áõ.
  • hemolytic disease of fetus/newborn
    žÆ/½Å»ý¾Æ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemolytic disease of newborn
    ½Å»ý¾Æ ¿ëÇ÷¼º Áúȯ
  • hemolytic disease of newborn
    ½Å»ý¾Æ¿ëÇ÷¼º Áúȯ.
  • hemorrhagic disease of newborn
    ½Å»ý¾ÆÃâÇ÷(¼º) Áúȯ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • screening hearing test
    ¼±º°Ã»·Â°Ë»ç
  • test, screening hearing
    ¼±º°Ã»·Â°Ë»ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • multiphasic screening test
    ´Ù»ó¼º(ËÀË×ËÛ) ½ºÅ©¸®´× Å×½ºÆ®.
  • prescreening development questionnaire for Denver developmental screening test
  • screening test
    ¼±º°°Ë»ç
  • hearing amelioration =hearing improvement, hearin
    û·Â°³¼±
  • hearing distance =hearing range
    û·Â°Å¸®, °¡Ã»°Å¸®
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º° °Ë»ç.
  • multiphasic health screening
    ´Ù»ó½Ä °Ç°­°ËÁø.
  • multiphasic screening
    ´Ù»ó¼º ¼±º°°Ë»ç.
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • screening
    ½ºÅ©¸®´×
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • screening test
    ¼±º°°Ë»ç
  • mass screening
    Áý´Ü°Ë»ç
  • Bachman intradermal test
    ¼±¸ðÃæÇdz»¹ÝÀÀ°Ë»ç
  • bentonite flocculation test
    º¥Å䳪ÀÌÆ®ÀÀÁý°Ë»ç
  • Casoni test
    Æ÷ÃæÇdz»¹ÝÀÀ°Ë»ç
  • circumoval precipitin test (COPT)
    Ãæ¶õÁÖÀ§Ä§°­°Ë»ç
  • intradermal test
    Çdz»¹ÝÀÀ°Ë»ç
  • Mazzotti test
    ¸¶Á¶Æ¼°Ë»ç
  • Montenegro test
    ¸óÅ״ϱ׷ΰ˻ç
  • Sabin-Feldman dye test
    (Åå¼ÒÆ÷ÀÚÃæ) »ö¼Ò¸é¿ª°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acrolein test
    ¾ÆÅ©·Ñ·¹ÀνÃÇè (ãËúÐ)
  • acute test
    ´Ü·® µ¶¼º½ÃÇè (Ó¤ÕáÔ¸àõãËúÐ)
  • adrenaline tolerance test
    ¾Æµå·¹³¯¸° ºÎÇϽÃÇè(ݶùÃãËúÐ)
  • albustix test
    ¾ËºÎ½ºÆ½½º½ÃÇè(ãËúÐ)
  • Ames test
    ¿¡ÀÓÁî °Ë»ç¹ý
  • antiglobulin consumption test
    Ç×(ù÷)±Û·ÎºÒ¸° ¼Ò¸ð½ÃÇè(á¼ÙÄãËúÐ)
  • antiglobulin test
    Ç×(ù÷)±Û·ÎºÒ¸° ½ÃÇè(ù÷ô÷ãËúÐ)
  • Aschheim-Zondek test
    ¾Æ»þÀÓ-Á¸µ¦ ½ÃÇè(ãËúÐ)
  • Ascoli test
    ¾Æ½ºÄݸ® ½ÃÇè(ãËúÐ)
  • Barfoed's test
    ¹Ù¸£ÆÐµå ½ÃÇè(ãËúÐ)
  • benzidine test
    º¥Áöµò½ÃÇè(ãËúÐ)
  • blind test
    ¸Í°Ë(ØîËþ)
  • Bradshaw test
    ºê·¡µå¼î¿ì ½ÃÇè(ãËúÐ)
  • capon test
    °Å¼¼(ËÛá§)´ß ½ÃÇè(ãËúÐ)
  • carbohydrate tolerance test
    ´çÁú ºÎÇϽÃÇè(ÓØòõݶùÃãËúÐ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • screening test
    ¼±º°°Ë»ç, ¿¹ºñ°Ë»ç
  • newborn
    ½Å»ýÀÇ, ½Å»ý¾ÆÀÇ, ½Å»ý¾Æ
  • newborn infant
    ½Å»ý¾Æ
  • pelvis perfusion test(Whitaker test)
    ½Å¿ì°ü·ù°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • screening
    ½ºÅ©¸®ÀÌ´×, ¼±º°¹ý
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã»
  • hearing aid
    º¸Ã»±â
  • hearing disturbance
    û·ÂÀå¾Ö
  • hearing loss
    û°¢¼Õ½Ç
  • sensorineural hearing loss
    °¨°¢½Å°æ¼º³­Ã»
  • arm to lung time test
    ÆÈÆó¼øÈ¯½Ã°£½ÃÇè
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • complement fixation test
    º¸Ã¼°áÇÕ½ÃÇè
  • contraction test
    ¼öÃà°Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DAST drug abuse screening test; drug and alcohol screening test
HT Hashimoto thyroiditis; hearing test; hearing threshold; heart; heart transplantation, heart transpla...
PAT Pain Apperception Test; paroxysmal atrial tachycardia; patient; phenylaminotetrazole; physical abili...
TST thiosulfate sulfur-transferase; thromboplastin screening test; total sleep time; transforming sequen...
HHIE-S Hearing Handicap Inventory for the Elderly-Screening Version
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
UNHS Universal newborn hearing screening
CHEST Chick Embrotoxicity Screening Test
CAST Children of Alcoholics Screening Test
DDST Denver Developmental Screening Test
MAST Michigan Alcohol Screening Test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Denver developmental screening test
    µ§¹ö ¹ßÀ° ¼±º° °Ë»ç, µ§¹ö ¹ßÀ° ¼±º°¹ý
    ¹ßÀ° ºÎÁøÀÌ ÀÖ´Â ¿µ¾Æ³ª ÇÐ·É Àü±â ¾Æµ¿À» ½Äº°ÇÏ´Â °Ë»ç¹ý.
  • screening test
    ¼±º° °Ë»ç, ¿¹ºñ °Ë»ç
  • epidemic diarrhea of the newborn
    ½Å»ý¾Æ À¯Ç༺ ¼³»çÁõ
  • newborn infant
    ½Å»ý¾Æ
  • period of newborn
    ½Å»ý¾Æ±â
  • speech hearing test
    ¾îÀ½ û·Â °Ë»ç
  • screening device
    °Ë»ö ±â±â
  • screening examination
    °£ÀÌ °Ë»ç
  • screening history
    °£ÀÌ º´·Â Á¶»ç
  • absolute hearing
    Àý´ë À½°¨
  • conductive hearing disturbance
    ÀüÀ½¼º ³­Ã»
  • familial progressive sensorineural hearing loss
    °¡Á·¼º ÁøÇ༺ °¨°¢ ½Å°æ¼º ³­Ã»
  • functional hearing loss
    ±â´É¼º ³­Ã»
  • hearing
    û°¢, û·Â, ûÃë
    µ¿ÀǾî=audition. À½À» ´À³¢´Â °¨°¢. À½À» ´À³¢´Â ´É·Â. ¾î¶² ¹üÀ§³»¿¡¼­ ¼Ò¸®¸¦ ÀÎÁöÇϰí ÀÌÇØÇÏ´Â °Í.
  • hearing aid
    º¸Ã»±â
    û°¢¿¡ ÀÌ»óÀÌ Àִ ȯÀÚµéÀÌ Àß µè±â À§ÇØ ±Í¿¡ ²Å¾Æ¼­ »ç¿ëÇÏ´Â ±â±¸.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
newborn screening Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism.
(12 Dec 1998)
screening test Any testing procedure designed to separate people or objects according to a fixed characteristic or property.
(05 Mar 2000)
Denver Developmental Screening Test A scale used by psychologists and paediatricians to assess the developmental, intellectual, motor, and social maturity of children at any age level from birth to adolescence.
(05 Mar 2000)
Weber's test for hearing The application of a vibrating tuning fork to one of several points in the midline of the head or face, to ascertain in which ear the sound is heard best by bone conduction, that ear being the affected one if the sound-conducting apparatus (middle ear) is at fault (positive test), but probably the normal one if the neurosensory apparatus is diseased (negative test).
(05 Mar 2000)
cancer, colon: screening and surveillance Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer.
(12 Dec 1998)
genetic screening The process of testing individuals to find out if they carry genes for certain known genetic diseases, such as sickle cell anaemia.
(09 Oct 1997)
carrier screening Indiscriminate examination of members of a population to detect heterozygotes for serious disorders and counsel about the risks of marriages with other carriers, and by antenatal diagnosis where a married couple are both carriers; often sacrifices precision to simplicity and is most effectively applied to populations known to be at high risk.
(05 Mar 2000)
mass screening Organised periodic procedures performed on large groups of people for the purpose of detecting disease.
(12 Dec 1998)
vision screening Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from vision tests, which are given to evaluate/measure individual visual performance not related to a specific population.
(12 Dec 1998)
multiphasic screening The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people.
(12 Dec 1998)
prenatal screening Screening for the detection of foetal disease, usually by ultrasound examination or by testing amniotic fluid obtained by amniocentesis. Other screening techniques include testing maternal serum and placental biopsy.
(05 Mar 2000)
cytologic screening A screening for the detection of early disease, usually cancer, through microscopic examination of a cellular specimen by inspecting each cell and structure present, usually at ×100 magnification with a mechanical stage, so that all areas are screened; the findings are evaluated and significant abnormalities are flagged (e.g., by dotting the cover slip) for further evaluation by a cytopathologist. This screening is usually performed by a cytotechnologist, but at times is done by automated machine prescreening.
(05 Mar 2000)
screening Examination of people with no symptoms, to detect unsuspected disease.
(16 Dec 1997)
screening audiometry Rapid measurement of the hearing of an individual or a group against a predetermined limit of normalcy; auditory responses to different frequencies presented at a constant intensity level are tested.
(05 Mar 2000)
neonatal screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • screening
    üÁúÇϱâ;½É»ç;°¡¸®±â;Â÷Æä
  • newborn
    °«³­
  • newborn
    °«(¹æ±Ý)ž;½Å»ýÀÇ;´Ù½Ã ž;¸¶À½À» °íÃĸÔÀº;ºÎȰÇÑ;½Å»ý¾Æ \
  • hearing
    ûÀ§;û·Â;°¡Ã»°Å¸®
  • hearing aid
    º¸Ã»±â
  • preliminary hearing
    ¿¹½É;¿¹ºñ ÇàÀ§;¿¹¼±
  • public hearing
    °øÃ»È¸
  • test
    ½ÃÇè,½ÃÇèÇÏ´Ù
  • Binet Simon test
    Áö³×½Ã¸ù½Ä Áö´É °Ë»ç¹ý
  • Dick test
    (ÀÇ)µñ Å×½ºÆ®(¼ºÈ«¿­ ÇǺΠ½ÃÇè)
  • Kline test
    Ŭ¶óÀÎ ½ÃÇè(¸Åµ¶ Ç÷ûÀÇ Ä§°­ ¹ÝÀÀ)
  • New Test.
    New Testament
  • Partial Test Ban Treaty
    ºÎºÐÀû ÇÙ½ÇÇè ±ÝÁö Á¶¾à
  • Rorschach test
    ·Î¸£»þÇÏ Å×½ºÆ®(À×Å©ÀÇ ¾ó·è°£Àº ¹«ÀǹÌÇÑ ¹«´Ì¸¦ ÇØ¼®½ÃÄÑ »ç¶÷ÀÇ ¼º°ÝµîÀ» ¾Ë¾Æ³»´Â °Ë»ç)
  • Wassermann test
    ¹Ù¼­¸¸ °Ë»ç(¹ÝÀÀ);¸Åµ¶ÀÇ Ç÷û Áø´Ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á